Kaia Health is a technology company.
Kaia Health has raised $120.0M across 5 funding rounds.
Key people at Kaia Health.
Kaia Health was founded by Manuel Thurner (Co-Founder and Co-CEO).
Kaia Health has raised $120.0M in total across 5 funding rounds.
Kaia Health was founded by Manuel Thurner (Co-Founder and Co-CEO).
Kaia Health has raised $120.0M in total across 5 funding rounds.
Kaia Health's investors include 3VC, 50 Partners, Accel, Balderton Capital, BootstrapLabs, CapitalX, Draper Associates, Earl Grey Capital, Eunoia Capital Partners, Eurazeo, Expa, Heartcore Capital.
Kaia Health is a leading digital therapeutics company that develops evidence-based mobile apps for managing musculoskeletal (MSK) pain, chronic obstructive pulmonary disease (COPD), and related conditions, using AI-powered computer vision for real-time exercise feedback without wearables.[1][2][3][4] It serves employers, health plans, insurers, and providers—covering over 60 million lives globally—with personalized, self-directed programs featuring exercises, relaxation, education, and human coaching, solving access barriers to affordable, non-pharmacological care outside clinics.[1][3][4] Backed by 11 clinical trials showing outcomes equivalent to traditional care at up to 80% lower cost and 3x ROI for partners, Kaia has grown to over 650,000 users and partnerships with firms like Fairway, Holcim, and Virgin Pulse, positioning it as the world's largest digital therapeutics provider.[3][4][6]
Founded in 2016 in Germany as a healthcare startup, Kaia Health emerged to address gaps in accessible therapy for back pain and COPD, leveraging the German Digital Healthcare Act that enabled prescribable digital apps (DiGA).[6] The company's proprietary motion analysis technology, pioneered since 2018 using smartphone cameras, quickly gained traction, leading to certifications, rapid global expansion to New York and Munich headquarters, and surpassing 500,000 users by early 2022 with 50 new clients.[3][6][7] Pivotal moments include eleven clinical trials validating efficacy, integration with platforms like Healthie for quick launches, and AWS infrastructure to scale services worldwide, fulfilling its vision of democratizing high-quality care.[4][5][6]
Kaia Health rides the digital therapeutics wave, fueled by regulatory shifts like Germany's DiGA and rising demand for scalable, remote MSK/COPD solutions amid healthcare shortages and post-pandemic telehealth adoption.[3][6] Its timing aligns with AI advancements in computer vision and multimodal care, countering market forces like clinic backlogs, high rehab costs, and chronic pain affecting millions—offering equitable access that reduces reliance on opioids or in-person visits.[1][2][4] By partnering with health plans covering 60+ million lives and validating ROI, Kaia influences the ecosystem, accelerating DTx adoption, lowering systemic costs, and paving the way for broader AI-health integrations.[3][4][9]
Kaia Health is primed to expand beyond MSK/COPD into more preventative programs, leveraging AWS for global scaling and new AI enhancements to serve even broader populations.[6] Trends like AI personalization, value-based care mandates, and insurer reimbursements for DTx will propel growth, potentially doubling user bases amid aging demographics and wellness-focused employers. Its influence may evolve from niche innovator to ecosystem standard-setter, further democratizing therapy—echoing its founding mission to empower healthiest lives anywhere.[3][7]
Key people at Kaia Health.
Kaia Health has raised $120.0M across 5 funding rounds. Most recently, it raised $75.0M Series C in April 2021.
